ASSURE Wearable ECG vs ClearRead CT
AI Verdict
Choose ASSURE Wearable ECG if…
Choose ASSURE Wearable ECG if your primary need is continuous, real-time cardiac monitoring and data collection for at-risk patients in an ambulatory setting. This non-therapeutic device is ideal for proactive management, providing automatic alerts and physiologic trend data for clinicians to review remotely.
View ASSURE Wearable ECG →Choose ClearRead CT if…
Choose ClearRead CT if your focus is on enhancing the diagnostic accuracy and efficiency of interpreting cardiothoracic CT scans. This AI suite is best suited for radiologists and pulmonologists seeking to improve pulmonary nodule detection, characterize findings, and perform coronary artery calcification analysis.
View ClearRead CT →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | ASSURE Wearable ECG | ClearRead CT |
|---|---|---|
| Pricing | Contact for pricing. | Contact for pricing |
| Deployment | Wearable device, mobile application, and cloud-based remote patient data platform. | On-premise (stand-alone server, virtual machine) and Cloud |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
ASSURE Wearable ECGTool A, the ASSURE Wearable ECG, is designed with a strong emphasis on patient comfort and intuitive use, featuring a 'SensorFit Garment' and 'Adaptive Patient Intelligence' to reduce motion artifacts, making it simple to wear and operate continuously. Its patient app is also described as easy to understand and very intuitive, directly enhancing the end-user experience.
Clinical Value
ClearRead CTClearRead CT offers quantifiable improvements in diagnostic accuracy and efficiency for radiologists, with a proven '29% reduction in missed actionable nodules' and 'up to 36% reduction in reading time'. It also demonstrates high agreement with ground truth radiologists for coronary artery calcification scoring. While Tool A shows strong effectiveness in arrhythmia detection and conversion, Tool B's direct, measurable impact on critical diagnostic outcomes and workflow efficiency gives it a slight edge.
Pricing & Value
TieBoth tools require direct contact for pricing information, making a transparent head-to-head comparison on this dimension impossible. While Tool B mentions various pricing models and potential cost savings through efficiency, Tool A also indicates a subscription model and rental nature, but neither provides public pricing details.
Enterprise Readiness
ASSURE Wearable ECGTool A explicitly states HIPAA compliance and BAA availability in its structured facts, and further details extensive privacy features and integration with major EHR/PACS systems. While Tool B operates with large healthcare institutions and is ISO27001 certified, its BAA and HIPAA compliance are listed as 'likely, contact vendor for details' in the provided facts, giving Tool A a slight advantage in documented transparency.
Innovation
ClearRead CTClearRead CT demonstrates significant pioneering innovation with its 'Patented Vessel Suppression (Clear Visual Intelligence)' technology and AI-driven diagnostic enhancements for CT scans. Riverain Technologies has a history of 'relentless innovation' and specific 'firsts' in AI-driven medical imaging, including early FDA approvals for CAD solutions.
Support & Docs
ASSURE Wearable ECGTool A provides a 24/7 ASSURE Helpline and offers patient-focused resources like a Patient Handbook, User Manual, and an 'ASSURE Assist service' for post-event support. This comprehensive, round-the-clock support, particularly for a patient-worn device, suggests a more immediate and accessible support structure compared to Tool B's standard business hours and clinician-focused resources.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | ASSURE Wearable ECG | ClearRead CT |
|---|---|---|
| Name | ASSURE Wearable ECG | ClearRead CT |
| Description/Purpose | A non-therapeutic device for continuous heart rate monitoring and data collection, integrated into a digital healthcare platform for at-risk cardiac patients. | An FDA-cleared AI suite enhancing pulmonary nodule detection and coronary artery calcification analysis in CT scans, improving diagnostic accuracy and streamlining radiology workflows. |
| Primary Categories | Cardiology AI, Wearables & Remote Monitoring (RPM) | Cardiology AI, Oncology AI, Radiology & Imaging AI |
| Target Specialties | Cardiology | Cardiology, Pulmonology, Radiology |
| Core Technology/Methodology | Wearable ECG device with SensorFit Garment and ASSURE Detection Algorithm with Quad Channel Processingu2122 for continuous heart rate monitoring. | AI suite with patented Vessel Suppression (Clear Visual Intelligence) for CT scan analysis. |
| Specific Diagnostic Capability | Continuous heart rate monitoring, automatic episode storage, alert-based notifications, physiologic trend data. | Pulmonary Nodule Detection (solid, part-solid, ground glass), Nodule Characterization and Measurement, Automated Nodule Tracking, Coronary Artery Calcification (CAC) Scoring. |
Videos
Demos, reviews, and walkthroughs featuring ASSURE Wearable ECG and ClearRead CT.